LifeMD Historical Income Statement

LFMD Stock

USD 5.86 0.26 4.64%

Historical analysis of LifeMD income statement accounts such as Total Revenue of 223.1 M can show how well LifeMD Inc performed in making a profits. Evaluating LifeMD income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of LifeMD's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining LifeMD Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether LifeMD Inc is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

About LifeMD Income Statement Analysis

LifeMD Inc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to LifeMD shareholders. The income statement also shows LifeMD investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

LifeMD Income Statement Chart

At present, LifeMD's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 76.3 M, whereas EBIT is forecasted to decline to (17 M).

Depreciation And Amortization Interest Expense Selling General Administrative Total Revenue Gross Profit

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Total Revenue

Total revenue comprises all receipts LifeMD Inc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of LifeMD Inc minus its cost of goods sold. It is profit before LifeMD operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from LifeMD's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into LifeMD Inc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

	2022	2023	2024	2025 (projected)
Interest Expense	1.3M	2.6M	2.2M	2.3M
Depreciation And Amortization	3.8M	6.6M	9.5M	10.0M

Interest Expense Depreciation And Amortization

LifeMD income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling And Marketing Expenses	Research Development	Discontinued Operations	Minority Interest	Net Interest Income	Net Income From Continuing Ops	Tax Provision	Reconciled Depreciation	Non Operating Income Net Other	Non Recurring
Depreciation And Amortization		0.69	0.89	0.96	0.98	0.9	-0.2	-0.2	-0.03	-0.54	0.9	-0.22	-0.39	-0.24	-0.25	0.86	1.0	0.64	-0.22	-0.69	-0.25	0.91	1.0	-0.78	-0.82
Interest Expense	0.69		0.88	0.83	0.77	0.9	-0.73	-0.72	-0.61	0.0	0.9	-0.75	-0.85	-0.76	0.06	0.92	0.69	0.83	-0.37	-1.0	-0.78	0.79	0.68	-0.87	-0.45
Selling General Administrative	0.89	0.88		0.96	0.94	0.99	-0.62	-0.62	-0.47	-0.3	0.99	-0.63	-0.69	-0.65	-0.09	0.98	0.89	0.8	-0.31	-0.88	-0.65	0.95	0.89	-0.87	-0.7
Total Revenue	0.96	0.83	0.96		0.99	0.98	-0.42	-0.43	-0.26	-0.39	0.98	-0.45	-0.61	-0.46	-0.17	0.96	0.96	0.75	-0.19	-0.83	-0.47	0.94	0.96	-0.9	-0.76
Gross Profit	0.98	0.77	0.94	0.99		0.95	-0.34	-0.34	-0.17	-0.52	0.95	-0.36	-0.51	-0.37	-0.3	0.93	0.98	0.71	-0.14	-0.77	-0.38	0.91	0.98	-0.84	-0.84
Other Operating Expenses	0.9	0.9	0.99	0.98	0.95		-0.59	-0.6	-0.45	-0.27	1.0	-0.62	-0.73	-0.63	-0.08	1.0	0.89	0.8	-0.23	-0.9	-0.64	0.95	0.9	-0.92	-0.69
Operating Income	-0.2	-0.73	-0.62	-0.42	-0.34	-0.59		1.0	0.98	-0.33	-0.59	1.0	0.87	1.0	-0.3	-0.64	-0.19	-0.62	0.26	0.71	0.99	-0.49	-0.2	0.55	0.07
Ebit	-0.2	-0.72	-0.62	-0.43	-0.34	-0.6	1.0		0.98	-0.34	-0.6	1.0	0.88	1.0	-0.32	-0.64	-0.2	-0.62	0.24	0.7	0.99	-0.5	-0.21	0.56	0.06
Ebitda	-0.03	-0.61	-0.47	-0.26	-0.17	-0.45	0.98	0.98		-0.44	-0.45	0.98	0.83	0.98	-0.37	-0.5	-0.02	-0.51	0.21	0.6	0.97	-0.35	-0.03	0.44	-0.08
Cost Of Revenue	-0.54	0.0	-0.3	-0.39	-0.52	-0.27	-0.33	-0.34	-0.44		-0.28	-0.33	-0.33	-0.34	0.88	-0.21	-0.58	-0.09	-0.22	-0.02	-0.36	-0.2	-0.57	0.02	0.8
Total Operating Expenses	0.9	0.9	0.99	0.98	0.95	1.0	-0.59	-0.6	-0.45	-0.28		-0.61	-0.73	-0.63	-0.08	0.99	0.9	0.8	-0.23	-0.89	-0.64	0.95	0.9	-0.92	-0.69
Income Before Tax	-0.22	-0.75	-0.63	-0.45	-0.36	-0.62	1.0	1.0	0.98	-0.33	-0.61		0.89	1.0	-0.3	-0.66	-0.21	-0.63	0.24	0.73	1.0	-0.51	-0.22	0.58	0.08
Total Other Income Expense Net	-0.39	-0.85	-0.69	-0.61	-0.51	-0.73	0.87	0.88	0.83	-0.33	-0.73	0.89		0.9	-0.3	-0.79	-0.37	-0.66	0.08	0.84	0.9	-0.61	-0.39	0.83	0.15
Net Income	-0.24	-0.76	-0.65	-0.46	-0.37	-0.63	1.0	1.0	0.98	-0.34	-0.63	1.0	0.9		-0.32	-0.67	-0.23	-0.64	0.27	0.75	1.0	-0.53	-0.24	0.6	0.08
Income Tax Expense	-0.25	0.06	-0.09	-0.17	-0.3	-0.08	-0.3	-0.32	-0.37	0.88	-0.08	-0.3	-0.3	-0.32		-0.05	-0.3	-0.06	-0.42	-0.09	-0.36	0.1	-0.29	-0.13	0.64
Selling And Marketing Expenses	0.86	0.92	0.98	0.96	0.93	1.0	-0.64	-0.64	-0.5	-0.21	0.99	-0.66	-0.79	-0.67	-0.05		0.86	0.81	-0.19	-0.92	-0.68	0.92	0.86	-0.94	-0.65
Research Development	1.0	0.69	0.89	0.96	0.98	0.89	-0.19	-0.2	-0.02	-0.58	0.9	-0.21	-0.37	-0.23	-0.3	0.86		0.64	-0.21	-0.69	-0.24	0.89	1.0	-0.76	-0.84
Discontinued Operations	0.64	0.83	0.8	0.75	0.71	0.8	-0.62	-0.62	-0.51	-0.09	0.8	-0.63	-0.66	-0.64	-0.06	0.81	0.64		-0.28	-0.82	-0.64	0.74	0.64	-0.7	-0.47
Minority Interest	-0.22	-0.37	-0.31	-0.19	-0.14	-0.23	0.26	0.24	0.21	-0.22	-0.23	0.24	0.08	0.27	-0.42	-0.19	-0.21	-0.28		0.39	0.31	-0.38	-0.18	0.09	-0.06
Net Interest Income	-0.69	-1.0	-0.88	-0.83	-0.77	-0.9	0.71	0.7	0.6	-0.02	-0.89	0.73	0.84	0.75	-0.09	-0.92	-0.69	-0.82	0.39		0.77	-0.8	-0.68	0.87	0.44
Net Income From Continuing Ops	-0.25	-0.78	-0.65	-0.47	-0.38	-0.64	0.99	0.99	0.97	-0.36	-0.64	1.0	0.9	1.0	-0.36	-0.68	-0.24	-0.64	0.31	0.77		-0.55	-0.25	0.62	0.07
Tax Provision	0.91	0.79	0.95	0.94	0.91	0.95	-0.49	-0.5	-0.35	-0.2	0.95	-0.51	-0.61	-0.53	0.1	0.92	0.89	0.74	-0.38	-0.8	-0.55		0.9	-0.87	-0.61
Reconciled Depreciation	1.0	0.68	0.89	0.96	0.98	0.9	-0.2	-0.21	-0.03	-0.57	0.9	-0.22	-0.39	-0.24	-0.29	0.86	1.0	0.64	-0.18	-0.68	-0.25	0.9		-0.78	-0.84
Non Operating Income Net Other	-0.78	-0.87	-0.87	-0.9	-0.84	-0.92	0.55	0.56	0.44	0.02	-0.92	0.58	0.83	0.6	-0.13	-0.94	-0.76	-0.7	0.09	0.87	0.62	-0.87	-0.78		0.49
Non Recurring	-0.82	-0.45	-0.7	-0.76	-0.84	-0.69	0.07	0.06	-0.08	0.8	-0.69	0.08	0.15	0.08	0.64	-0.65	-0.84	-0.47	-0.06	0.44	0.07	-0.61	-0.84	0.49

Click cells to compare fundamentals

LifeMD Account Relationship Matchups

LifeMD income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	397.8K	868.8K	3.8M	6.6M	9.5M	10.0M
Interest Expense	1.7M	3.0M	1.3M	2.6M	2.2M	2.3M
Selling General Administrative	42.2M	39.6M	47.0M	51.7M	72.7M	76.3M
Total Revenue	37.3M	92.9M	119.0M	152.5M	212.5M	223.1M
Gross Profit	28.4M	74.9M	100.4M	133.6M	242.4M	254.5M
Other Operating Expenses	95.1M	147.2M	158.7M	167.0M	228.6M	240.0M
Operating Income	(57.8M)	(54.3M)	(39.7M)	(14.5M)	(16.1M)	(17.0M)
Ebit	(57.8M)	(54.8M)	(43.4M)	(14.8M)	(16.1M)	(17.0M)
Ebitda	(57.4M)	(53.9M)	(39.6M)	(8.2M)	(6.7M)	(7.0M)
Cost Of Revenue	8.9M	18.0M	18.7M	18.9M	(29.9M)	(28.4M)
Total Operating Expenses	86.2M	129.2M	140.1M	148.5M	204.5M	214.8M
Income Before Tax	(60.4M)	(61.3M)	(44.7M)	(17.4M)	(18.3M)	(19.2M)
Total Other Income Expense Net	(2.6M)	(7.0M)	(5.0M)	(2.9M)	(2.2M)	(2.3M)
Net Income	(60.5M)	(61.3M)	(45.0M)	(20.6M)	(18.9M)	(19.8M)
Income Tax Expense	122.5K	7.7K	360.7K	428K	(402K)	(381.9K)
Selling And Marketing Expenses	41.7M	82.5M	78.4M	76.5M	103.0M	108.2M
Research Development	446.7K	778.8K	3.0M	6.1M	9.5M	10.0M
Net Income Applicable To Common Shares	(3.1M)	(63.4M)	(61.8M)	(48.6M)	(43.8M)	(41.6M)
Minority Interest	(2.2M)	426.4K	514.6K	(2.6M)	(153.2K)	(160.9K)
Net Interest Income	(1.7M)	(3.0M)	(1.3M)	(2.8M)	(2.2M)	(2.3M)
Net Income From Continuing Ops	(60.5M)	(61.3M)	(45.0M)	(26.2M)	(18.7M)	(19.7M)
Tax Provision	122.5K	7.7K	360.7K	428K	402K	422.1K
Reconciled Depreciation	397.8K	868.8K	3.8M	5.9M	9.5M	10.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:

How To Invest In LifeMD

Details

Is LifeMD Stock a good investment?

Details

What is LifeMD's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.53)

Revenue Per Share

5.157

Quarterly Revenue Growth

0.432

Return On Assets

(0.15)

Return On Equity

(24.63)

The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

LifeMD Historical Income Statement

About LifeMD Income Statement Analysis

LifeMD Income Statement Chart

Depreciation And Amortization

Interest Expense

Total Revenue

Gross Profit

LifeMD income statement Correlations

LifeMD Account Relationship Matchups

High Positive Relationship

High Negative Relationship

LifeMD income statement Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Research Development	+ 1.0	Depreciation And Amortization
Reconciled Depreciation	+ 1.0	Depreciation And Amortization
Total Operating Expenses	+ 1.0	Other Operating Expenses
Selling And Marketing Expenses	+ 1.0	Other Operating Expenses
Ebit	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Operating Income

Net Interest Income	- 1.0	Interest Expense
Non Operating Income Net Other	- 0.94	Selling And Marketing Expenses
Net Interest Income	- 0.92	Selling And Marketing Expenses
Non Operating Income Net Other	- 0.92	Total Operating Expenses
Non Operating Income Net Other	- 0.92	Other Operating Expenses
Net Interest Income	- 0.9	Other Operating Expenses